Aminologics Co.Ltd (074430) — Cash Flow-to-Debt Ratio
Aminologics Co.Ltd (074430) has a Cash Flow-to-Debt Ratio of 0.15x as of March 2026, meaning its operating cash flow of ₩4.62 Billion could theoretically repay 0% of its total liabilities (₩30.52 Billion) in one year. See Aminologics Co.Ltd (074430) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Aminologics Co.Ltd Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Aminologics Co.Ltd across 13 annual periods. For the full cash flow conversion analysis, see Aminologics Co.Ltd cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Aminologics Co.Ltd (2008–2025)
Year-by-year debt coverage analysis for Aminologics Co.Ltd. Check Aminologics Co.Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | ₩2.54 Billion | ₩28.18 Billion | ▼ -93.9% |
| 2024 | 1.47x | ₩7.47 Billion | ₩5.09 Billion | ▲ +2288.3% |
| 2023 | -0.07x | ₩-218.15 Million | ₩3.26 Billion | ▼ -105.4% |
| 2022 | 1.25x | ₩5.23 Billion | ₩4.18 Billion | ▲ +682.1% |
| 2021 | 0.16x | ₩935.52 Million | ₩5.85 Billion | ▼ -40.6% |
| 2020 | 0.27x | ₩1.77 Billion | ₩6.57 Billion | ▼ -55.8% |
| 2019 | 0.61x | ₩3.60 Billion | ₩5.92 Billion | ▼ -51.0% |
| 2018 | 1.24x | ₩4.56 Billion | ₩3.67 Billion | ▲ +75.0% |
| 2017 | 0.71x | ₩3.00 Billion | ₩4.23 Billion | ▼ -23.2% |
| 2016 | 0.92x | ₩4.14 Billion | ₩4.48 Billion | ▲ +223.5% |
| 2015 | 0.29x | ₩1.93 Billion | ₩6.75 Billion | ▲ +193.8% |
| 2014 | -0.30x | ₩-2.07 Billion | ₩6.78 Billion | ▼ -134.4% |
| 2008 | 0.89x | ₩12.19 Billion | ₩13.77 Billion | — |